Cited by 352Autism Spectrum Disorder ResearchNeurotransmitter Receptor Influence on BehaviorGenetics and Neurodevelopmental Disorders

Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism

Nakamura, Kazuhiko, Sekine, Yoshimoto, Ouchi, Yasuomi, Tsujii, Masatsugu, Yoshikawa, Etsuji, Futatsubashi, Masami, Tsuchiya, Kenji J., Sugihara, Genichi +7 more·2010·Archives of General Psychiatry

Abstract

CONTEXT: Autism is a neurodevelopmental disorder that is characterized by repetitive and/or obsessive interests and behavior and by deficits in sociability and communication. Although its neurobiological underpinnings are postulated to lie in abnormalities of the serotoninergic and dopaminergic systems, the details remain unknown. OBJECTIVE: To determine the occurrence of changes in the binding of serotonin and dopamine transporters, which are highly selective markers for their respective neuronal systems. DESIGN: Using positron emission tomography, we measured the binding of brain serotonin and dopamine transporters in each individual with the radioligands carbon 11 ((11)C)-labeled trans-1,2,3,5,6,10-beta-hexahydro-6-[4-(methylthio)phenyl]pyrrolo-[2,1-a]isoquinoline ([(11)C](+)McN-5652) and 2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane ([(11)C]WIN-35,428), respectively. Statistical parametric mapping was used for between-subject analysis and within-subject correlation analysis with respect to clinical variables. SETTING: Participants recruited from the community. PARTICIPANTS: Twenty men (age range, 18-26 years; mean [SD] IQ, 99.3 [18.1]) with autism and 20 age- and IQ-matched control subjects. RESULTS: Serotonin transporter binding was significantly lower throughout the brain in autistic individuals compared with controls (P < .05, corrected). Specifically, the reduction in the anterior and posterior cingulate cortices was associated with the impairment of social cognition in the autistic subjects (P < .05, corrected). A significant correlation was also found between repetitive and/or obsessive behavior and interests and the reduction of serotonin transporter binding in the thalamus (P < .05, corrected). In contrast, the dopamine transporter binding was significantly higher in the orbitofrontal cortex of the autistic group (P < .05, corrected in voxelwise analysis). In the orbitofrontal cortex, the dopamine transporter binding was significantly inversely correlated with serotonin transporter binding (r = -0.61; P = .004). CONCLUSIONS: The brains of autistic individuals have abnormalities in both serotonin transporter and dopamine transporter binding. The present findings indicate that the gross abnormalities in these neurotransmitter systems may underpin the neurophysiologic mechanism of autism. Our sample was not characteristic or representative of a typical sample of adults with autism in the community.

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2009.137

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Group-level abnormalities of serotonergic and dopaminergic transporter activity have been reported in individuals with ASD, but the results are mixed, presumably due to the spectrum nature of ASD.

    “While group-level abnormalities of serotonergic and dopaminergic transporter activity have been reported by previous studies using single-photon emission computed tomography and positron emission tomography in individuals with ASD (119, 120), the results are mixed, presumably due to the spectrum nature of ASD.”
  • A PET study reported elevated dopamine transporter levels in orbitalfrontal cortex in high functioning autism subjects.

    “In a PET study, elevated dopamine transporter levels were reported in the orbitalfrontal cortex in high functioning autism subjects [182].”
  • A PET study found reduced serotonin transporter binding in anterior and posterior cingulate cortex in high functioning autistic subjects, associated with impaired social cognition, and in thalamus associated with repetitive/obsessive behavior.

    “In a PET imaging study, serotonin transporter binding was reduced in the anterior and posterior cingulate cortex in high functioning autistic subjects associated with impaired social cognition and, in the thalamus associated with repetitive and /or obsessive behavior and interests [182].”
  • A recent study with a relatively large sample found evidence of higher DAT binding in the orbitofrontal cortex in ASD.

    “although a recent study with a relatively large sample found evidence of higher DAT binding in the orbitofrontal cortex in ASD [586].”
  • These neurotransmitter systems play key roles in neurotransmission, brain maturation, cortical organisation, and behaviours including social and repetitive behaviour.

    “These systems play key roles in neurotransmission, brain maturation, cortical organisation and behaviours (including social behaviour and repetitive behaviour) [180,181,182,183,184].”

    From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [184]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., Tsuchiya, K. J., Sugihara, G., Iwata, Y., Suzuki, K., Matsuzaki, H., Suda, S., Sugiyama, T., Takei, N., & Mori, N.
Affiliations
Hamamatsu University School of Medicine (JP)
Venue
Archives of General Psychiatry
Published
2010-01-01
Volume
67
Issue
1
Pages
59
ISSN
0003-990X (ISSN-L)
OpenAlex
W1976644675
Cited by
352
References
81
Citations by year
2026: 8 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 22 · 2021: 35 · 2020: 24 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 13 · 2015: 29 · 2014: 31 · 2013: 28 · 2012: 26
FWCI
16.63
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, serotonin transporter binding, dopamine transporter binding, high-functioning autism, serotonergic system, dopaminergic system, social cognition, cingulate cortex, thalamus, orbitofrontal cortex, neuroimaging biomarkers, autistic adults, positron emission tomography, neurobiology of autism
MeSH terms
Adolescent, Adult, Autistic Disorder, Brain, Brain Mapping, Carbon Radioisotopes, Dopamine, Humans, Isoquinolines, Male, Serotonin, Biomarkers, Membrane Transport Proteins, Positron-Emission Tomography, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review